Literature DB >> 17410961

Exclusion of students with conjunctivitis from school: policies of state departments of health.

Christina M Ohnsman1.   

Abstract

PURPOSE: To use current state department of health regulations regarding exclusion of students with conjunctivitis from school as a starting point in developing uniform recommendations for schools.
METHODS: State departments of health were asked to state their policy regarding when a child with conjunctivitis may return to school. This information was collated and examined for trends. The results were compared with current literature on infectious conjunctivitis.
RESULTS: Of the 43 states that responded, 7 allow children with conjunctivitis to remain in school, 8 allow their return once antibiotic treatment is initiated, 12 allow their return 24 hours after antibiotics are initiated, 13 exclude them until the disease is noncommunicable, and 16 require the approval of a physician for return to school. Seventeen states gave multiple recommendations, which were often contradictory.
CONCLUSIONS: Although no current consensus exists among state health officials regarding students with conjunctivitis, the literature supports excluding children with conjunctivitis from school until they are asymptomatic. When patients are treated with fourth-generation fluoroquinolones, the length of exclusion may be as little as 24 hours in cases of bacterial conjunctivitis, and longer in cases of viral conjunctivitis. Following these guidelines may prevent epidemics of bacterial and viral conjunctivitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17410961

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  7 in total

Review 1.  Moxifloxacin 0.5% ophthalmic solution: in bacterial conjunctivitis.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2011-01-01       Impact factor: 9.546

Review 2.  Conjunctivitis: a systematic review of diagnosis and treatment.

Authors:  Amir A Azari; Neal P Barney
Journal:  JAMA       Date:  2013-10-23       Impact factor: 56.272

3.  Ophthalmic antibiotic use for acute infectious conjunctivitis in children.

Authors:  Holly M Frost; Thresia Sebastian; Josh Durfee; Timothy C Jenkins
Journal:  J AAPOS       Date:  2021-11-02       Impact factor: 1.325

4.  Success of Masking 5% Povidone-Iodine Treatment: The Reducing Adenoviral Patient Infected Days Study.

Authors:  Meredith M Whiteside; Ellen S Shorter; Mathew S Margolis; Fatima Alvi; Julia B Huecker; Tammy P Than; Mary K Migneco; Jennifer S Harthan; Christina E Morettin; Andrew T E Hartwick; Spencer D Johnson; Chamila D Perera; Mae O Gordon
Journal:  Optom Vis Sci       Date:  2021-05-01       Impact factor: 1.973

5.  Antibiotic Prescription Fills for Acute Conjunctivitis among Enrollees in a Large United States Managed Care Network.

Authors:  Nakul S Shekhawat; Roni M Shtein; Taylor S Blachley; Joshua D Stein
Journal:  Ophthalmology       Date:  2017-06-16       Impact factor: 14.277

6.  Antibiotic resistance among bacterial conjunctival pathogens collected in the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study.

Authors:  Penny A Asbell; Heleen H DeCory
Journal:  PLoS One       Date:  2018-10-18       Impact factor: 3.240

Review 7.  A Review of the Differential Diagnosis of Acute Infectious Conjunctivitis: Implications for Treatment and Management.

Authors:  Elizabeth Yeu; Scott Hauswirth
Journal:  Clin Ophthalmol       Date:  2020-03-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.